
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation Operating Cycle 2011-2026 | CO
Annual Operating Cycle Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 186 | 138 | 94 | 101 | 136 | 144 | 139 | 180 | 87.4 | 104 | 116 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 202 | 87.4 | 136 |
Quarterly Operating Cycle Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 54.4 | - | - | - | 76.7 | - | - | - | 40 | - | - | - | 50.7 | - | - | - | 60.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96.3 | 180 | - | - | 74.5 | 187 | 220 | 120 | 60.4 | 55.8 | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 220 | 40 | 98.1 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
161 | $ 121.25 | 2.54 % | $ 36.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 21.33 | -5.2 % | $ 230 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 22.09 | -1.47 % | $ 1.18 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.52 | 4.12 % | $ 2.02 M | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 25.08 | 2.13 % | $ 697 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 183.47 | 3.69 % | $ 9.09 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
143 | $ 195.86 | 1.07 % | $ 140 B | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 519.83 | 0.81 % | $ 15 B | ||
|
Illumina
ILMN
|
198 | $ 134.35 | 1.23 % | $ 21.4 B | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 5.19 | 3.7 % | $ 481 M | ||
|
NeoGenomics
NEO
|
102 | $ 8.38 | 2.63 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.64 | 4.33 % | $ 2.09 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 16.34 | 1.3 % | $ 494 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 29.83 | 4.17 % | $ 20 B | ||
|
Precipio
PRPO
|
43.8 | $ 28.81 | -0.66 % | $ 46.2 M | ||
|
Guardant Health
GH
|
128 | $ 90.83 | 5.99 % | $ 11.4 B | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
275 | $ 2.83 | - | $ 91.8 K | ||
|
Biomerica
BMRA
|
204 | $ 2.18 | -0.91 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 119.42 | 3.32 % | $ 9.85 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 273.05 | 2.51 % | $ 22.7 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.8 | 0.44 % | $ 284 M | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.67 | 0.18 % | $ 2.68 B | ||
|
Lantheus Holdings
LNTH
|
121 | $ 84.14 | 0.26 % | $ 5.68 B | ||
|
Neuronetics
STIM
|
69.1 | $ 1.44 | 2.86 % | $ 95 M | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 195.61 | 2.17 % | $ 21.7 B | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 6.01 | 16.27 % | $ 4.73 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 526.97 | 2.13 % | $ 199 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.68 | -2.63 % | $ 61.9 M |